Wesbanco Bank Inc. Sells 26,451 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Wesbanco Bank cut its UnitedHealth Group stake by 42.2% in the first quarter, selling 26,451 shares and leaving it with 36,164 shares worth about $9.79 million.
• Wall Street sentiment on UNH remains upbeat, with multiple analysts reiterating buy/outperform ratings and price targets raised as high as $475; the consensus rating is Moderate Buy with an average target of $410.79.
• UnitedHealth also saw insider selling, as CEO Patrick Hugh Conway sold 800 shares at $355 each, while the company recently reported better-than-expected earnings and raised its quarterly dividend to $2.32 per share.

Wesbanco Bank Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.2% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,164 shares of the healthcare conglomerate's stock after selling 26,451 shares during the period. Wesbanco Bank Inc.'s holdings in UnitedHealth Group were worth $9,786,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the business. Brighton Jones LLC grew its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $340,000. Flow Traders U.S. LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth about $356,000. Finally, Jump Financial LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at about $377,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on UNH shares. Sanford C. Bernstein reiterated an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday. Bank of America upped their price target on shares of UnitedHealth Group from $450.00 to $475.00 and gave the company a "buy" rating in a research report on Wednesday. Oppenheimer lifted their price target on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an "outperform" rating in a report on Wednesday, April 22nd. Argus upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price objective for the company in a report on Wednesday, April 22nd. Finally, Royal Bank Of Canada lifted their target price on UnitedHealth Group from $361.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $410.79.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company's stock, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.28% of the company's stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wall Street sentiment remains constructive, with multiple firms reiterating bullish ratings and several recent price-target increases, including a new $475 target from BofA Securities. That suggests analysts see room for further upside as margins and Optum Health improve. What to Expect From UnitedHealth Group's Q2 2026 Earnings Report
• Positive Sentiment: Investors appear to be rotating into healthcare as a defensive play while technology stocks weaken, which is supporting demand for UNH shares. Social-media chatter also points to continued interest in the company’s recovery narrative and its resilient insurance and medical-services business. UnitedHealth Group Stock (UNH) Opinions on Market Rotation and Analyst Upgrades
• Positive Sentiment: Market coverage ahead of the Q2 2026 report says analysts expect double-digit EPS growth, reinforcing the idea that earnings could justify the stock’s recent move higher. What to Expect From UnitedHealth Group's Q2 2026 Earnings Report
• Neutral Sentiment: Recent articles also frame UNH as a long-term value and healthcare watchlist name, which supports investor interest but does not by itself add a fresh catalyst.

UnitedHealth Group Stock Up 2.9%

Shares of NYSE UNH opened at $427.47 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $427.93. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The company's 50 day moving average price is $383.92 and its 200-day moving average price is $332.44. The company has a market capitalization of $388.21 billion, a P/E ratio of 32.29, a price-to-earnings-growth ratio of 1.67 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the firm earned $7.20 earnings per share. UnitedHealth Group's quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were paid a dividend of $2.32 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. UnitedHealth Group's payout ratio is currently 70.09%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.